Lv1
50 积分 2025-11-18 加入
Milestones in tumor vascularization and its therapeutic targeting
8天前
已完结
Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal Antibody
8天前
已完结
Pharmacology and Pharmacodynamics of Bevacizumab as Monotherapy or in Combination with Cytotoxic Therapy in Preclinical Studies
9天前
已完结
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
9天前
已完结
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
9天前
已完结
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
9天前
已完结
Viral mimicry may help explain immunogenic cell death
9天前
已完结
Discovery of novel antibody-drug conjugates bearing tissue protease specific linker with both anti-angiogenic and strong cytotoxic effects
10天前
已完结
The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics
14天前
已完结
An FDA oncology analysis of toxicities associated with PBD-containing antibody-drug conjugates
16天前
已完结
皖公网安备34019202002308
